Home » Newsletters » BioWorld Science

BioWorld Science

July 20, 1999

View Archived Issues

New topical ciclosporin formulation effective for site-specific immunosuppression

Intercardia restructures relationship with Interneuron, changes name to Incara

Cantab's therapeutic vaccine for genital warts enters phase II trials

New Amgen compounds for disorders mediated by TNF-alpha, collagenase and/or stromelysin

Wide series of factor Xa inhibitors specifically claimed by DuPont

Effective hypoglycemic agents arise from U.S.-French collaborative effort

Takeda patents inhibitors of ICAM-1/ELAM-1 expression for immune, autoimmune disorders

Pharmacia & Upjohn's new oxazolidinones exhibit weak or no MAO inhibition

Roche claims another series acting as OFQ receptor antagonists

Zambon presents phthalazines useful for Rx of inflammatory/allergic disorders

Peptoids with antibacterial activity designed by Chiron and collaborators

Hodgkin's lymphoma cell discovered by international team

Ilex acquires Convergence and expands anticancer pipeline

Short-course nevirapine effective in reducing mother-to-infant transmission of HIV

Everninomicin antibiotic effective in patients with penicillin-resistant pneumonia

E-5564 and E-5531: novel endotoxin antagonists discussed at Birmingham meeting

Sibia licenses transcription-based assay technology to Pharmacia & Upjohn

ProNeura completes proof-of-concept studies for sustained drug delivery system

Potential drug interactions with ZD-0870 evaluated in humans

Pharmacokinetics of linezolid not affected by liver disease

Behavioral effects of new third-generation SERM and known nonsteroidal ER ligands

In vitro antibacterial activity of DK-35C discussed at recent congress

Rotavirus vaccine temporarily suspended due to reports of intussusception

New steroids with potential as androgen receptor-mediated imaging agents

Chilean researchers investigate potential new treatments for Chagas' disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...